Related Experiment Video
Updated: May 18, 2026
06:35
An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
[Prognosis of giant cell arteritis]
Christian Agard1, Olivier Espitia, Antoine Néel
1CHU de Nantes, pôle médecine-cancer-hématologie, hôpital Hôtel-Dieu, centre de compétence maladies systémiques et auto-immunes rares, service de médecine interne, 44093 Nantes cedex 01, France. christian.agard@chu-nantes.fr
Presse Medicale (Paris, France : 1983)
|September 7, 2012
Summary
Giant cell arteritis (GCA) poses risks of vision loss and increased early mortality from cardiovascular events. While long-term survival is generally good, complications from GCA and its treatments require careful management.
Area of Science:
- Rheumatology
- Ophthalmology
- Cardiology
Context:
- Giant cell arteritis (GCA) is a systemic vasculitis affecting large arteries.
- Short-term prognosis is dominated by the risk of irreversible vision loss.
- Long-term survival is generally not impaired, but cardiovascular complications are a concern.
Purpose:
- To summarize the key prognostic factors and complications associated with giant cell arteritis.
- To highlight the risks of visual impairment and cardiovascular mortality.
- To discuss steroid-related complications and their management.
Summary:
- Giant cell arteritis (GCA) carries a 5-20% risk of permanent vision loss, primarily due to anterior ischemic optic neuropathy.
- While 5-year survival approaches 80%, increased mortality in the first year post-diagnosis is linked to cardiovascular disorders like aortitis, stroke, and myocardial infarction.
- Steroid treatment can lead to complications such as infections and osteoporosis (20-40% of cases), though preventive measures have improved outcomes.
Impact:
- Informs clinical practice regarding GCA patient monitoring and risk stratification.
- Emphasizes the need for early diagnosis and aggressive management to prevent vision loss and cardiovascular events.
- Highlights the importance of managing steroid-induced side effects for improved patient prognosis.
Related Concept Videos
01:26Aneurysm III: Interprofessional Care
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:12Chronic Inflammation: Introduction
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
01:21Aneurysm II: Clinical Manifestations and Diagnostic Studies
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
01:25Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...